Anti-PAR2 Antibody is a neutralizing monoclonal antibody targeting Protease-activated Receptor 2 (PAR2). By specifically binding to its extracellular domain and interfering with protease-mediated receptor activation, this antibody effectively inhibits downstream inflammatory signaling and nociceptive transmission, and is commonly used in studies of acute/chronic inflammation, neurogenic pain, and dermatological conditions.